Prevalence of precancerous lesions and conditions in India: A systematic review and meta-analysis

doi:10.5662/wjm.v12.i4.293

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5063)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

246

WORD

HTML

2237

Figures (1-3)

194

Tables (1-5)

245

Sum=3012

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

252

Download

810

Sum=1062

Publishing Process of This Article

Item

Count

Browse

332

Download

657

Sum=989

Jul 20, 2022 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Methodol. Jul 20, 2022; 12(4): 293-304
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.293

Table 2 Meta-Analyses for the point estimate of various pre-cancerous lesions and conditions

Precancerous lesions and conditions (Event/n)	No of estimates included	Point prevalence (95%CI)	I²(%)
LKP¹(16828/901715)	92	4.3 (4.0-4.6)	99.47
LKP²(23090/653349)	46	6.7 (6.0-7.3)	99.74
LKP³(39918/1555064)	138	4.9 (4.7-5.2)	99.65
ERP¹(223/20,164)	12	1.2 (0.7-1.7)	94.97
ERP²(1112/275674)	6	2.5 (0.4-4.5)	99.15
ERP³(1335/295838)	18	1.4 (1.0-1.7)	97.91
PL¹(4353/488610)	16	5.8 (4.4-7.2)	99.49
PL²(8148/57951)	19	11.5 (8.0-15.0)	99.81
PL³(12501/546561)	35	8.9 (7.4-10.3)	99.77
OSMF¹(9229/749768)	50	2.7 (2.5-3.0)	99.18
OSMF²(8160/487272)	38	4.5 (4.2-4.9)	99.58
OSMF³ (17389/1237040)	88	3.4 (3.2-3.6)	99.43
LP¹(2759/233782)	48	1.1 (0.9-1.2)	97.59
LP²(3811/50300)	25	7.5 (5.3-9.6)	99.92
LP³(6570/627947)	73	1.2 (1.1-1.3)	98.14

¹Community-based studies.

²Hospital based studies.

³Pooled community and hospital based studies.

LKP: Leukoplakia; ERP: Erythroplakia; PL: Palatal lesion; OSMF: Oral Submucous fibrosis; LP: Lichen planus.

Citation: Kumbhalwar A, Shetiya SH, Kakodkar P, Mehta V, Mathur A, Porwal P. Prevalence of precancerous lesions and conditions in India: A systematic review and meta-analysis. World J Methodol 2022; 12(4): 293-304
URL: https://www.wjgnet.com/2222-0682/full/v12/i4/293.htm
DOI: https://dx.doi.org/10.5662/wjm.v12.i4.293